Literature DB >> 22029501

Chronic spinal compression model in minipigs: a systematic behavioral, qualitative, and quantitative neuropathological study.

Roman Navarro1, Stefan Juhas, Sassan Keshavarzi, Jana Juhasova, Jan Motlik, Karl Johe, Silvia Marsala, Miriam Scadeng, Peter Lazar, Zoltan Tomori, Gery Schulteis, Michael Beattie, Joseph D Ciacci, Martin Marsala.   

Abstract

The goal of the present study was to develop a porcine spinal cord injury (SCI) model, and to describe the neurological outcome and characterize the corresponding quantitative and qualitative histological changes at 4-9 months after injury. Adult Gottingen-Minnesota minipigs were anesthetized and placed in a spine immobilization frame. The exposed T12 spinal segment was compressed in a dorso-ventral direction using a 5-mm-diameter circular bar with a progressively increasing peak force (1.5, 2.0, or 2.5 kg) at a velocity of 3 cm/sec. During recovery, motor and sensory function were periodically monitored. After survival, the animals were perfusion fixed and the extent of local SCI was analyzed by (1) post-mortem MRI analysis of dissected spinal cords, (2) qualitative and quantitative analysis of axonal survival at the epicenter of injury, and (3) defining the presence of local inflammatory changes, astrocytosis, and schwannosis. Following 2.5-kg spinal cord compression the animals demonstrated a near complete loss of motor and sensory function with no recovery over the next 4-9 months. Those that underwent spinal cord compression with 2 kg force developed an incomplete injury with progressive partial neurological recovery characterized by a restricted ability to stand and walk. Animals injured with a spinal compression force of 1.5 kg showed near normal ambulation 10 days after injury. In fully paralyzed animals (2.5 kg), MRI analysis demonstrated a loss of spinal white matter integrity and extensive septal cavitations. A significant correlation between the magnitude of loss of small and medium-sized myelinated axons in the ventral funiculus and neurological deficits was identified. These data, demonstrating stable neurological deficits in severely injured animals, similarities of spinal pathology to humans, and relatively good post-injury tolerance of this strain of minipigs to spinal trauma, suggest that this model can successfully be used to study therapeutic interventions targeting both acute and chronic stages of SCI.

Entities:  

Mesh:

Year:  2012        PMID: 22029501      PMCID: PMC3278823          DOI: 10.1089/neu.2011.2076

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  44 in total

1.  Tolerance across a two-haplotype, fully MHC-mismatched barrier induced in miniature swine renal allografts treated with a 12-day course of tacrolimus.

Authors:  R Utsugi; R N Barth; H Kitamura; J Ambroz; D H Sachs; K Yamada
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  From spinal shock to spasticity: neuronal adaptations to a spinal cord injury.

Authors:  L P Hiersemenzel; A Curt; V Dietz
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

3.  An electron-microscopic analysis of axonal alterations following blunt contusion of the spinal cord of the rhesus monkey (Macaca mulatta).

Authors:  J C Bresnahan
Journal:  J Neurol Sci       Date:  1978-06       Impact factor: 3.181

4.  A simple and reproducible model of spinal cord injury induced by epidural balloon inflation in the rat.

Authors:  I Vanický; L Urdzíková; K Saganová; D Cízková; J Gálik
Journal:  J Neurotrauma       Date:  2001-12       Impact factor: 5.269

5.  Up-regulation of CD81 (target of the antiproliferative antibody; TAPA) by reactive microglia and astrocytes after spinal cord injury in the rat.

Authors:  S Dijkstra; J R Geisert EE; W H Gispen; P R Bär; E A Joosten
Journal:  J Comp Neurol       Date:  2000-12-11       Impact factor: 3.215

6.  Schwann cells are removed from the spinal cord after effecting recovery from paraplegia.

Authors:  L Jasmin; G Janni; T M Moallem; D A Lappi; P T Ohara
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

7.  A neuroanatomical analysis of spinal cord injury in the rhesus monkey (Macaca mulatta).

Authors:  J C Bresnahan; J S King; G F Martin; D Yashon
Journal:  J Neurol Sci       Date:  1976-08       Impact factor: 3.181

Review 8.  The pathology of human spinal cord injury: defining the problems.

Authors:  Michael D Norenberg; Jon Smith; Alex Marcillo
Journal:  J Neurotrauma       Date:  2004-04       Impact factor: 5.269

9.  Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling.

Authors:  A R Blight
Journal:  Neuroscience       Date:  1983-10       Impact factor: 3.590

10.  Microcirculatory disturbances during the early phase following experimental spinal cord trauma in the rat.

Authors:  S Sasaki; H Schneider; S Renz
Journal:  Adv Neurol       Date:  1978
View more
  23 in total

1.  Potential variables affecting the quality of animal studies regarding pathophysiology of traumatic spinal cord injuries.

Authors:  Z Hassannejad; M Sharif-Alhoseini; A Shakouri-Motlagh; F Vahedi; S A Zadegan; M Mokhatab; M Rezvan; S Saadat; F Shokraneh; V Rahimi-Movaghar
Journal:  Spinal Cord       Date:  2015-12-22       Impact factor: 2.772

2.  Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington's Disease and Human Blood Plasma.

Authors:  Hanadi Ananbeh; Jaromir Novak; Stefan Juhas; Jana Juhasova; Jiri Klempir; Kristyna Doleckova; Irena Rysankova; Karolina Turnovcova; Jaroslav Hanus; Hana Hansikova; Petr Vodicka; Helena Kupcova Skalnikova
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

Review 3.  Translational spinal cord injury research: preclinical guidelines and challenges.

Authors:  Paul J Reier; Michael A Lane; Edward D Hall; Y D Teng; Dena R Howland
Journal:  Handb Clin Neurol       Date:  2012

Review 4.  Spinal cord injury: how can we improve the classification and quantification of its severity and prognosis?

Authors:  Vibhor Krishna; Hampton Andrews; Abhay Varma; Jacobo Mintzer; Mark S Kindy; James Guest
Journal:  J Neurotrauma       Date:  2014-02-01       Impact factor: 5.269

Review 5.  Spinal cord injury pharmacotherapy: Current research & development and competitive commercial landscape as of 2015.

Authors:  Jason R Guercio; Jason E Kralic; Eric J Marrotte; Michael L James
Journal:  J Spinal Cord Med       Date:  2018-02-27       Impact factor: 1.985

Review 6.  The Next Generation of Biomarker Research in Spinal Cord Injury.

Authors:  Elke Ydens; Ilse Palmers; Sven Hendrix; Veerle Somers
Journal:  Mol Neurobiol       Date:  2016-02-05       Impact factor: 5.590

Review 7.  Pain assessment in animal models: do we need further studies?

Authors:  Carmelo Gigliuto; Manuela De Gregori; Valentina Malafoglia; William Raffaeli; Christian Compagnone; Livia Visai; Paola Petrini; Maria Antonietta Avanzini; Carolina Muscoli; Jacopo Viganò; Francesco Calabrese; Tommaso Dominioni; Massimo Allegri; Lorenzo Cobianchi
Journal:  J Pain Res       Date:  2014-05-08       Impact factor: 3.133

8.  Filter-probe diffusion imaging improves spinal cord injury outcome prediction.

Authors:  Nathan P Skinner; Seung-Yi Lee; Shekar N Kurpad; Brian D Schmit; L Tugan Muftuler; Matthew D Budde
Journal:  Ann Neurol       Date:  2018-07-03       Impact factor: 11.274

Review 9.  Large animal models for stem cell therapy.

Authors:  John Harding; R Michael Roberts; Oleg Mirochnitchenko
Journal:  Stem Cell Res Ther       Date:  2013-03-28       Impact factor: 6.832

10.  Amelioration of motor/sensory dysfunction and spasticity in a rat model of acute lumbar spinal cord injury by human neural stem cell transplantation.

Authors:  Sebastiaan van Gorp; Marjolein Leerink; Osamu Kakinohana; Oleksandr Platoshyn; Camila Santucci; Jan Galik; Elbert A Joosten; Marian Hruska-Plochan; Danielle Goldberg; Silvia Marsala; Karl Johe; Joseph D Ciacci; Martin Marsala
Journal:  Stem Cell Res Ther       Date:  2013-05-28       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.